Jinxin Fertility Group Ltd
HKEX:1951
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2.09
4.42
|
| Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Jinxin Fertility Group Ltd
Jinxin Fertility Group Ltd
Revenue
Jinxin Fertility Group Ltd
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Jinxin Fertility Group Ltd
HKEX:1951
|
Revenue
¥2.8B
|
CAGR 3-Years
25%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
|
Guangzhou Kingmed Diagnostics Group Co Ltd
SSE:603882
|
Revenue
¥7.8B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
Topchoice Medical Co Inc
SSE:600763
|
Revenue
¥2.9B
|
CAGR 3-Years
1%
|
CAGR 5-Years
10%
|
CAGR 10-Years
18%
|
|
|
Nanjing Xinjiekou Department Store Co Ltd
SSE:600682
|
Revenue
¥6.7B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
7%
|
|
|
Dian Diagnostics Group Co Ltd
SZSE:300244
|
Revenue
¥12.4B
|
CAGR 3-Years
0%
|
CAGR 5-Years
8%
|
CAGR 10-Years
26%
|
|
|
Meinian Onehealth Healthcare Holdings Co Ltd
SZSE:002044
|
Revenue
¥10.7B
|
CAGR 3-Years
4%
|
CAGR 5-Years
5%
|
CAGR 10-Years
27%
|
|
Jinxin Fertility Group Ltd
Glance View
Jinxin Fertility Group Ltd. engages in the provision of assisted reproductive, management and ancillary medical services. The company is headquartered in Chengdu, Sichuan. The company went IPO on 2019-06-25. The firm operates its business through three segments. The ARS segment primarily provides its patients with two treatment solutions: artificial insemination (AI) and in vitro fertilization (IVF) technology. The Management Services segment provides management services to Jinjiang IVF Center and Jinxin Fertility Center. The Ancillary Medical Services segment mainly provides medical services in the areas of gynecology, urology and internal medicine through Shenzhen Zhongshan Hospital. The firm mainly operates its business in China and the Unites.
See Also
What is Jinxin Fertility Group Ltd's Revenue?
Revenue
2.8B
CNY
Based on the financial report for Dec 31, 2023, Jinxin Fertility Group Ltd's Revenue amounts to 2.8B CNY.
What is Jinxin Fertility Group Ltd's Revenue growth rate?
Revenue CAGR 5Y
25%
Over the last year, the Revenue growth was 18%. The average annual Revenue growth rates for Jinxin Fertility Group Ltd have been 25% over the past three years , 25% over the past five years .
You don't have any saved screeners yet
